NSG 552 Exam 1 Mood Stabilizers 2026 – 70+ Practice Questions on Lithium, Valproate, Lamotrigine & Bipolar Disorder Management

This comprehensive NSG 552 Exam 1 Mood Stabilizers study guide contains over 70 high-yield practice questions and answers covering the pharmacologic management of bipolar disorders, mood stabilizer mechanisms, therapeutic drug monitoring, medication safety, and evidence-based prescribing principles essential for advanced psychiatric nursing practice. Designed for graduate nursing students and advanced practice providers, this resource transforms complex psychopharmacology concepts into an active recall format that strengthens clinical judgment, enhances medication safety awareness, and improves performance on psychiatric nursing examinations and PMHNP certification assessments. The material integrates therapeutic indications, laboratory monitoring, adverse effect recognition, and treatment algorithms frequently emphasized in psychopharmacology coursework and advanced psychiatric practice. The guide begins with an in-depth review of bipolar disorder management, emphasizing lithium as the gold standard treatment for Bipolar I Disorder and one of the few psychotropic agents associated with demonstrated anti-suicidal and neuroprotective properties. Students will strengthen their understanding of FDA-approved maintenance therapies for bipolar disorder, including lithium, aripiprazole, lamotrigine, and olanzapine, while exploring the clinical factors that influence medication selection across acute, maintenance, and rapid-cycling presentations. The resource also reinforces the recognition of manic and depressive symptom clusters through the DIGFAST and SIGECAPS frameworks to support diagnostic accuracy and treatment planning. Extensive coverage of lithium pharmacotherapy examines therapeutic serum concentrations, baseline laboratory requirements, monitoring schedules, and the recognition of early versus late toxicity manifestations. Learners will review appropriate pretreatment assessments, including thyroid function studies, renal function tests, pregnancy screening, complete blood counts, metabolic panels, and electrocardiographic evaluation in high-risk populations. Topics include factors that elevate lithium concentrations, such as dehydration, NSAID use, ACE inhibitors, thiazide diuretics, sodium depletion, renal impairment, and age-related physiological changes. Clinical emphasis is placed on patient education regarding hydration, sodium intake consistency, and prompt recognition of toxicity symptoms to prevent life-threatening complications. The resource provides detailed examination of anticonvulsant mood stabilizers commonly utilized in bipolar disorder management. Students will explore carbamazepine's role as a preferred option in rapid-cycling bipolar disorder, including its therapeutic range, auto-induction properties, baseline laboratory monitoring, black box warnings for agranulocytosis and aplastic anemia, and recognition of hematologic complications. Valproic acid pharmacology is reviewed extensively through discussions of therapeutic serum levels, monitoring requirements, adverse effect profiles, thrombocytopenia risk, hepatotoxicity, hyperammonemia, and evidence-based interventions such as L-carnitine administration and hemodialysis in toxicity scenarios. Comprehensive review of lamotrigine emphasizes its role in bipolar maintenance therapy and the critical importance of gradual dose titration to minimize the risk of Stevens-Johnson syndrome. Students will strengthen their understanding of common adverse effects, clinically significant drug interactions, and dose adjustments required when co-administered with valproic acid. The guide further addresses additional mood stabilizers including topiramate, gabapentin, and pregabalin, highlighting their unique clinical applications, benefits, and limitations within psychiatric practice. Special emphasis is placed on reproductive safety and medication selection in vulnerable populations. Learners will review teratogenic risks associated with valproic acid, carbamazepine, and lithium, including neural tube defects and Ebstein anomaly, while integrating these considerations into patient-centered treatment planning. Additional content examines the risks associated with antidepressant use in bipolar disorder, including antidepressant-induced switching from depressive episodes to mania, reinforcing the importance of evidence-based prescribing practices. The guide also reviews antipsychotic agents approved for acute and maintenance treatment phases of bipolar disorder, combination therapies for bipolar depression, clinically significant drug interactions, and laboratory monitoring recommendations essential for safe medication management. These concepts strengthen diagnostic reasoning, improve prescribing confidence, and prepare learners for advanced psychiatric clinical practice. This study guide is particularly valuable for Psychiatric Mental Health Nurse Practitioner (PMHNP) students, Master of Science in Nursing (MSN) students, Doctor of Nursing Practice (DNP) students, psychiatric nursing students, advanced practice registered nurses, physician assistant students specializing in behavioral health, psychiatry residents, nurse practitioner certification candidates, and healthcare professionals seeking a focused review of mood stabilizer pharmacotherapy and bipolar disorder management. The content aligns with established evidence-based practice standards and authoritative references, including: Stahl, S. M. (2024). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (6th ed.). Cambridge University Press. Stahl, S. M. (2024). Stahl's Essential Psychopharmacology Prescriber's Guide (8th ed.). Cambridge University Press. American Psychiatric Association. (2024). Practice recommendations for the treatment of Bipolar Disorder and mood stabilization strategies. Yatham, L. N., Kennedy, S. H., Parikh, S. V., et al. (2023). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) Guidelines for the Management of Bipolar Disorder. Townsend, M. C., & Morgan, K. I. (2024). Psychiatric Mental Health Nursing: Concepts of Care in Evidence-Based Practice (11th ed.). F.A. Davis. Sadock, B. J., Sadock, V. A., & Ruiz, P. (2022). Kaplan & Sadock's Synopsis of Psychiatry (12th ed.). Wolters Kluwer. Designed as both an intensive examination review and a practical psychopharmacology companion, this study guide promotes active learning, strengthens prescribing confidence, enhances medication safety awareness, and prepares learners to integrate evidence-based mood stabilizer therapy into advanced psychiatric nursing practice. Keywords: NSG 552, NSG 552 Exam 1, Mood stabilizers, Psychopharmacology, Bipolar disorder, Bipolar I disorder, Bipolar maintenance therapy, Lithium, Lithium toxicity, Lithium monitoring, Therapeutic lithium levels, Antisuicidal properties, Neuroprotective effects, Carbamazepine, Rapid cycling bipolar disorder, Carbamazepine toxicity, Agranulocytosis, Aplastic anemia, Valproic acid, Divalproex sodium, Hyperammonemia, L-carnitine, Lamotrigine, Stevens-Johnson syndrome, Topiramate, Cognitive slowing, Gabapentin, Pregabalin, Bipolar depression, Mania, DIGFAST, SIGECAPS, Antidepressant-induced mania, Mood stabilizer pharmacology, Bipolar treatment guidelines, Pregnancy considerations, Neural tube defects, Ebstein anomaly, CBC monitoring, Liver function tests, Renal function monitoring, TSH monitoring, Therapeutic drug monitoring, PMHNP exam preparation, Psychiatric nursing review, Advanced psychopharmacology, Nurse practitioner certification review